Shoulder Innovations (SI) Stock Overview
Designs, develops, manufactures, and distributes implant systems for shoulder arthroplasty in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
SI Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Shoulder Innovations, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$19.34 |
| 52 Week High | US$24.60 |
| 52 Week Low | US$10.92 |
| Beta | 0 |
| 1 Month Change | -13.58% |
| 3 Month Change | 24.05% |
| 1 Year Change | 47.18% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 28.51% |
Recent News & Updates
SI: Higher 2026 Guidance And Margin Outlook Will Support Further Upside
Analysts recently adjusted their price target for Shoulder Innovations from $23.00 to $26.25, citing updated assumptions around discount rates, revenue growth, profit margins, and future P/E expectations as key drivers of the change. What’s in the News for Shoulder Innovations Shoulder Innovations raised its earnings guidance for the year 2026, according to a recent key developments filing.SI: Raised 2026 Revenue Outlook Will Shape A More Measured Future
Analysts have lifted their price target for Shoulder Innovations from $20.60 to $23.00 as they update their models for a slightly lower discount rate, adjusted revenue growth and profit margin assumptions, and a revised future P/E outlook. What’s in the News for Shoulder Innovations Shoulder Innovations raised its full year 2026 net revenue guidance to a range of $65 million to $68 million, according to a key developments filing.Recent updates
SI: Higher 2026 Guidance And Margin Outlook Will Support Further Upside
Analysts recently adjusted their price target for Shoulder Innovations from $23.00 to $26.25, citing updated assumptions around discount rates, revenue growth, profit margins, and future P/E expectations as key drivers of the change. What’s in the News for Shoulder Innovations Shoulder Innovations raised its earnings guidance for the year 2026, according to a recent key developments filing.SI: Raised 2026 Revenue Outlook Will Shape A More Measured Future
Analysts have lifted their price target for Shoulder Innovations from $20.60 to $23.00 as they update their models for a slightly lower discount rate, adjusted revenue growth and profit margin assumptions, and a revised future P/E outlook. What’s in the News for Shoulder Innovations Shoulder Innovations raised its full year 2026 net revenue guidance to a range of $65 million to $68 million, according to a key developments filing.
Focused Surgeon Coverage And Enabling Technology Will Drive Sustained Shoulder Arthroplasty Momentum
Catalysts About Shoulder Innovations Shoulder Innovations develops shoulder arthroplasty implant systems and related enabling technologies for shoulder surgeons. What are the underlying business or industry changes driving this perspective?Analysts Have Made A Financial Statement On Shoulder Innovations, Inc.'s (NYSE:SI) First-Quarter Report
It's been a pretty great week for Shoulder Innovations, Inc. ( NYSE:SI ) shareholders, with its shares surging 18% to...Is Shoulder Innovations (NYSE:SI) Weighed On By Its Debt Load?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Shoulder Innovations: Interesting, But Not Having My Backing Yet
Summary Shoulder Innovations trades at 4x sales with strong top line momentum but faces ongoing operating losses and product concentration risks. Its revenue guidance was raised to $45.5M for 2025, with Q3 sales up 58% year-over-year and sequential growth expected. Despite manageable losses and a $122M net cash position, Shoulder Innovations' growth and margin improvements are needed to justify valuation. I remain cautiously interested, noting Shoulder Innovations' takeover potential and awaiting Q4 results and 2026 guidance for further clarity. Read the full article on Seeking AlphaShareholder Returns
| SI | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -14.4% | 4.1% | 1.0% |
| 1Y | 47.2% | -11.1% | 18.4% |
Return vs Industry: SI exceeded the US Medical Equipment industry which returned -10.6% over the past year.
Return vs Market: SI exceeded the US Market which returned 19% over the past year.
Price Volatility
| SI volatility | |
|---|---|
| SI Average Weekly Movement | 11.5% |
| Medical Equipment Industry Average Movement | 8.6% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: SI's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: SI's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 74 | Rob Ball | www.shoulderinnovations.com |
Shoulder Innovations, Inc. designs, develops, manufactures, and distributes implant systems for shoulder arthroplasty in the United States. It designs InSet Glenoid technology that aims to reduce mechanical stress at the bone implant interface, improve fixation mechanics, enhance stability, and reduce micromotion. The company was incorporated in 2009 and is headquartered in Grand Rapids, Michigan.
Shoulder Innovations, Inc. Fundamentals Summary
| SI fundamental statistics | |
|---|---|
| Market cap | US$408.68m |
| Earnings (TTM) | -US$35.03m |
| Revenue (TTM) | US$60.06m |
Is SI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SI income statement (TTM) | |
|---|---|
| Revenue | US$60.06m |
| Cost of Revenue | US$13.61m |
| Gross Profit | US$46.45m |
| Other Expenses | US$81.48m |
| Earnings | -US$35.03m |
Last Reported Earnings
Jun 30, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.68 |
| Gross Margin | 77.34% |
| Net Profit Margin | -58.33% |
| Debt/Equity Ratio | 11.9% |
How did SI perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/08/12 04:01 |
| End of Day Share Price | 2026/08/12 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Shoulder Innovations, Inc. is covered by 5 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Gorman | BTIG |
| David Roman | Goldman Sachs |
| Matthew Taylor | Jefferies LLC |